UA122865U - A METHOD OF IMPROVING THE RELAXATION OF VASCULAR MUSCULARS AT THE ACCOUNT OF THE RESTORATION OF HYDROGEN SYNTHESIS AT AGING - Google Patents

A METHOD OF IMPROVING THE RELAXATION OF VASCULAR MUSCULARS AT THE ACCOUNT OF THE RESTORATION OF HYDROGEN SYNTHESIS AT AGING

Info

Publication number
UA122865U
UA122865U UAU201708907U UAU201708907U UA122865U UA 122865 U UA122865 U UA 122865U UA U201708907 U UAU201708907 U UA U201708907U UA U201708907 U UAU201708907 U UA U201708907U UA 122865 U UA122865 U UA 122865U
Authority
UA
Ukraine
Prior art keywords
relaxation
improving
aging
musculars
restoration
Prior art date
Application number
UAU201708907U
Other languages
Ukrainian (uk)
Inventor
Лідія Анатоліївна Мись
Наталія Андріївна Струтинська
Наталя Олександрівна Дорофеєва
Вадим Федорович Сагач
Original Assignee
Інститут Фізіології Ім. О.О. Богомольця Нану
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Фізіології Ім. О.О. Богомольця Нану filed Critical Інститут Фізіології Ім. О.О. Богомольця Нану
Priority to UAU201708907U priority Critical patent/UA122865U/en
Publication of UA122865U publication Critical patent/UA122865U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Спосіб покращення розслаблення гладеньких м'язів судин за рахунок відновлення рівнів синтезу сірководню при старінні включає введення вітаміну. Як органічну хімічну сполуку /вітаміну/ використовують кофактор Н2S-синтезуючих ферментів піридоксаль-5-фосфат, пероральне введення якого у дозі 0,7 мг/кг впродовж 14 днів підвищує вміст сірководню і, як наслідок, збільшує розслаблення судин при старінні.A method of improving vascular smooth muscle relaxation by restoring levels of hydrogen sulfide synthesis during aging involves the introduction of vitamin A. As an organic chemical / vitamin / compound, the cofactor of H2S-synthesizing enzymes pyridoxal-5-phosphate is used, the oral administration of which at a dose of 0.7 mg / kg for 14 days increases the content of hydrogen sulfide and, as a consequence, increases the relaxation of blood vessels during aging.

UAU201708907U 2017-09-07 2017-09-07 A METHOD OF IMPROVING THE RELAXATION OF VASCULAR MUSCULARS AT THE ACCOUNT OF THE RESTORATION OF HYDROGEN SYNTHESIS AT AGING UA122865U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201708907U UA122865U (en) 2017-09-07 2017-09-07 A METHOD OF IMPROVING THE RELAXATION OF VASCULAR MUSCULARS AT THE ACCOUNT OF THE RESTORATION OF HYDROGEN SYNTHESIS AT AGING

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201708907U UA122865U (en) 2017-09-07 2017-09-07 A METHOD OF IMPROVING THE RELAXATION OF VASCULAR MUSCULARS AT THE ACCOUNT OF THE RESTORATION OF HYDROGEN SYNTHESIS AT AGING

Publications (1)

Publication Number Publication Date
UA122865U true UA122865U (en) 2018-01-25

Family

ID=61006525

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201708907U UA122865U (en) 2017-09-07 2017-09-07 A METHOD OF IMPROVING THE RELAXATION OF VASCULAR MUSCULARS AT THE ACCOUNT OF THE RESTORATION OF HYDROGEN SYNTHESIS AT AGING

Country Status (1)

Country Link
UA (1) UA122865U (en)

Similar Documents

Publication Publication Date Title
MX2022015272A (en) Inhibitors of kras g12c protein and uses thereof.
MX2022015115A (en) Methods of treating heart failure with cardiac sarcomere activators.
PE20190338A1 (en) METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
MX2010002498A (en) Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol.
MX2022006663A (en) Oxygen-containing heterocyclic compound, preparation method and application thereof.
AR083395A1 (en) NMU PEPTIDIC DERIVATIVE (NEUROMEDINA U) WITH ELEVATED ANORECTIC EFFECT
MX2022001225A (en) Method for improving digestive health.
MX2022009736A (en) P2X<sub>3</sub> AND/OR P2X<sub>2/3</sub> COMPOUNDS AND METHODS.
PH12021550713A1 (en) Medicament for the treatment of chronic cough
MX2023012095A (en) Hdac6 inhibitors for use in the treatment of dilated cardiomyopathy.
PH12020551076A1 (en) Methods for treating diabetes, hepatitis, and/or inflammatory liver disease
MX2021007453A (en) Perineural administration of resiniferatoxin for treatment of maladaptive pain.
AU2018282105A1 (en) Dosing of vibegron for treatment of overactive bladder
CR20220280A (en) Combination therapy comprising an alk2 inhibitor and a jak2 inhibitor
MX2023010673A (en) Nitrogen-containing heterocyclic ketones, preparation methods and medicinal uses thereof.
WO2020146700A8 (en) Lipid nanoparticles
WO2020079489A3 (en) Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs
UA122865U (en) A METHOD OF IMPROVING THE RELAXATION OF VASCULAR MUSCULARS AT THE ACCOUNT OF THE RESTORATION OF HYDROGEN SYNTHESIS AT AGING
BR112021018084A8 (en) DRUG AND METHOD FOR TREATMENT OR PREVENTION OF COMPLICATIONS OF DIABETES USING THE SAME DRUG
BR112019004896A2 (en) sublingual or buccal administration of dim for the treatment of skin diseases
CA3199014A1 (en) Combination therapy for the treatment of a liver disease
MX2018008555A (en) Use of long-term fasting mimicking as dietary treatment for multiple myeloma and other cancers.
MX2023000198A (en) Atr inhibitors and uses thereof.
AU2019284008A1 (en) Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders
MX2021004138A (en) Methods and formulations for treating chemotherapy-induced nausea and vomiting.